CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses

Katie E. Lineburg(QIMR Berghofer Medical Research Institute), Stéphanie Gras(La Trobe University), Corey Smith(QIMR Berghofer Medical Research Institute), Srividhya Swaminathan(The University of Queensland), Christopher Szeto(La Trobe University), Dhilshan Jayasinghe(La Trobe University), Alan Riboldi‐Tunnicliffe(Australian Nuclear Science and Technology Organisation), Lea Lekieffre(QIMR Berghofer Medical Research Institute), Kirsty R. Short(The University of Queensland), Emma J. Grant(La Trobe University), Zhen Tong(The University of Queensland), Weisan Chen(La Trobe University), Lloyd D’Orsogna(The University of Western Australia), Hannah Sloane(La Trobe University), Demetra S.M. Chatzileontiadou(La Trobe University), Rajiv Khanna(QIMR Berghofer Medical Research Institute), Hanim Halim(Monash University), Christian A. Lobos(La Trobe University), Andrea Nguyen(Monash Health), Archana Panikkar(QIMR Berghofer Medical Research Institute), Michelle A. Neller(QIMR Berghofer Medical Research Institute), Keng Yih Chew(Australian Research Council), Jyothy Raju(QIMR Berghofer Medical Research Institute), Pauline Crooks(QIMR Berghofer Medical Research Institute), Jacqueline M. Burrows(QIMR Berghofer Medical Research Institute), Sweera Rehan(QIMR Berghofer Medical Research Institute)

Immunity

April 15, 2021

Cited by 206

Related Papers

|Seminars in Cell and Developmental Biology|2015|602

|Proceedings of the National Academy of Sciences|2004|440

|Nature Medicine|2018|282

|Frontiers in Cellular and Infection Microbiology|2018|282

|Cancer Discovery|2019|272